Tranexamic acid infusion for high-risk surgery patients
Part of Blood & lymphatic, Digestive system clinical trials.
This trial tests whether giving tranexamic acid through an IV during surgery can reduce bleeding in patients with high-risk conditions like obesity, heart problems, diabetes, or blood clotting issues. It may help make surgery safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery and are considered high-risk
- You have a body mass index (BMI) over 45
- You have a pre-existing condition like high blood pressure, diabetes, heart disease, thyroid problems, or a bleeding disorder
- You do not have active blood clots or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This trial tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during weight loss surgery. If you are having a sleeve gastrectomy or mini-gastric bypass, taking TXA may lower your risk of hemorrhagic events.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
This Phase 3 trial tests whether tranexamic acid can reduce bleeding during major spine fusion surgery for adults with scoliosis or spine degeneration. It may help lessen blood loss and the need for transfusions, while monitoring safety.
Hear when a new Obese Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.